Labcorp introduces first trimester screening test to assess preeclampsia risk during pregnancy

Labcorp is now the only lab that can detect preeclampsia risk across all pregnancy trimesters burlington, n.c. , may 15, 2024 /prnewswire/ -- labcorp (nyse: lh), a global leader of innovative and comprehensive laboratory services, announced today the launch of its first trimester preeclampsia screening test to be performed between 11 and 14 weeks gestation to determine the risk of developing preeclampsia before 34 weeks of pregnancy.
LH Ratings Summary
LH Quant Ranking